Craig Gracey Sells 2,084 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 2,084 shares of Omada Health stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $20.00, for a total value of $41,680.00. Following the completion of the sale, the chief accounting officer directly owned 2,941 shares of the company’s stock, valued at approximately $58,820. This trade represents a 41.47% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Craig Gracey also recently made the following trade(s):

• On Monday, June 29th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $21.00, for a total value of $43,743.00.
• On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $19.01, for a total transaction of $39,597.83.
• On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $18.00, for a total transaction of $37,494.00.
• On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The stock was sold at an average price of $17.42, for a total transaction of $120,093.48.

Omada Health Stock Up 3.1%

NASDAQ OMDA opened at $22.62 on Thursday. The firm has a market cap of $1.34 billion and a P/E ratio of -83.78. The company’s 50 day moving average is $17.00 and its 200-day moving average is $14.98. Omada Health, Inc. has a 12-month low of $10.28 and a 12-month high of $26.92.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.03. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The company had revenue of $78.05 million during the quarter. Equities analysts expect that Omada Health, Inc. will post -0.01 EPS for the current year.

Institutional Investors Weigh In On Omada Health

Institutional investors have recently made changes to their positions in the business. Geode Capital Management LLC purchased a new stake in Omada Health during the 2nd quarter valued at about $637,000. Walleye Capital LLC purchased a new stake in shares of Omada Health in the 2nd quarter worth about $458,000. Ilex Capital Partners UK LLP bought a new stake in Omada Health during the 2nd quarter valued at approximately $201,000. Soros Fund Management LLC bought a new stake in shares of Omada Health during the second quarter valued at approximately $640,000. Finally, Raymond James Financial Inc. bought a new stake in shares of Omada Health during the 2nd quarter valued at $32,000.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on OMDA shares. Weiss Ratings raised Omada Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, June 26th. JPMorgan Chase & Co. decreased their price target on Omada Health from $32.00 to $26.00 and set an “overweight” rating on the stock in a research report on Thursday, March 12th. Wells Fargo & Company increased their price target on shares of Omada Health from $17.00 to $18.00 and gave the stock an “equal weight” rating in a report on Friday, May 8th. The Goldman Sachs Group restated a “buy” rating on shares of Omada Health in a research report on Friday, May 8th. Finally, Evercore reaffirmed an “outperform” rating and set a $20.00 target price on shares of Omada Health in a report on Friday, May 8th. Ten analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $22.91.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.